Family CFO’s AbbVie ABBV Stock Holding History

Family CFO’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20	Closed	-$4.57K	–	43
2025 Q4	$4.57K	Buy	+20	New	+$4.56K	﹤0.01%	76
2025 Q3	–	Sell	-20	Closed	-$3.71K	–	36
2025 Q2	$3.71K	Buy	+20	New	+$3.72K	﹤0.01%	82
2025 Q1	–	Sell	-20	Closed	-$3.55K	–	66
2024 Q4	$3.55K	Buy	+20	New	+$3.68K	﹤0.01%	78

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Family CFO's ABBV Position: Q1 2026 in Review

Family CFO sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 20 shares — an estimated $4.57K sold.

Family CFO first reported a position in ABBV in Q4 2024 and held it in 3 quarters. The position peaked at $4.57K in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Family CFO reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
Family CFO sold 20 AbbVie shares in Q1 2026, an estimated $4.57K.
Family CFO first reported a position in AbbVie in Q4 2024 and held it in 3 quarters.
Family CFO's AbbVie position peaked at $4.57K in Q4 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Family CFO's 13F filing for Q1 2026, filed 28 Apr 2026.